Shilpa Medicare932.05
+7.50 (+0.81%)

Shilpa Medicare Share Price

932.05+7.50 (+0.81%)
+164.15% past 1 Year

News

Shilpa Medicare Receives European GMP Certification For Jadcherla Facility

Equity
SHILPAMED
10 Oct 2026

Shilpa Medicare HYDERABAD UNIT GETS USFDA PROCESS REMARK AFTER INSPECTION

Equity
SHILPAMED
18 Sept 2026

Shilpa Medicare gets US FDA final approval for Oeris marketing authorization

Equity
SHILPAMED
11 Sept 2026

Shilpa Medicare gets SEC final approval for Oeris extended-release injection launch in India

Equity
SHILPAMED
11 Sept 2026

Shilpa Medicare starts voluntary recall of chemotherapy drug vials in US market

Equity
SHILPAMED
18 Aug 2026

Shilpa Medicare guides for sustained growth, faster profitability and tax normalization

Equity
SHILPAMED
6 Aug 2026

Shilpa Medicare plans FY27 human trials for first ADC biosimilar program

Equity
SHILPAMED
6 Aug 2026

Shilpa Medicare targets Semaglutide DMF filing completion by first half FY27

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare to begin European commercial supplies in 2H FY27

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare management confident of stronger results by FY27

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare onco block expansion progresses toward FY27 completion

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare Q1 EBITDA rises with slight improvement in margin performance

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare Q1 revenue surges year-on-year on strong operating performance

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare reports higher quarterly net profit in Q1

Equity
SHILPAMED
5 Aug 2026

Shilpa Medicare appoints Dr. Uday N. Harle as new Chief Executive Officer

Equity
SHILPAMED
3 Aug 2026

Shilpa Medicare inks EU-GMP nivolumab biosimilar deal with Orion for Europe

Equity
SHILPAMED
30 Jun 2026

Shilpa Medicare commissions advanced GMP oncology CDMO manufacturing facility

Equity
SHILPAMED
24 Jun 2026

Shilpa Medicare forms strategic partnership with Gate2Brain for brain cancer therapy

Equity
SHILPAMED
8 Jun 2026

Shilpa Medicare partners Gate2Brain for 30.4% stake to target brain cancer

Equity
SHILPAMED
3 Jun 2026

Shilpa Medicare gets CDSCO approval for global Phase 3 plan for Albumin

Equity
SHILPAMED
22 May 2026

Shilpa Medicare Ltd Share Price Today

The Shilpa Medicare Ltd share price today is ₹1064.3. During the trading session, the Shilpa Medicare Ltd share price opened at ₹1044 and recorded an intraday high of ₹1095 and a low of ₹1034.6. Last closing price was ₹1047.2. Over the past 52 weeks, the Shilpa Medicare Ltd share price has ranged between ₹259.5 and ₹1095. The current Shilpa Medicare Ltd stock price reflects real-time market activity based on executed trades on the exchange.